Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation.

Leukemia & lymphoma - 1 Dec 2022

Ishitsuka Kantaro, Yoshizawa Yuki, Nishikii Hidekazu, Kusakabe Manabu, Ito Yufu, Inadome Yukinori, Sakamoto Tatsuhiro, Kato Takayasu, Kurita Naoki, Yokoyama Yasuhisa, Obara Naoshi, Hasegawa Yuichi, Nannya Yasuhito, Ogawa Seishi, Sakata-Yanagimoto Mamiko, Chiba Shigeru

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AMP-Activated Protein Kinase Kinases
Share to Mast Cells
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins c-kit

Share to Translocation, Genetic

Source

Identifiers

PMID: 36126964
DOI: 10.1080/10428194.2022.2123235

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation.PMID 36126964Read ↗

De novo leukemic variant of mast cell leukemia with KIT D816V.Semantic proximity Read ↗

<i>KIT</i> and MastocytosisSemantic proximity Read ↗

Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant.Semantic proximity Read ↗

Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His.Semantic proximity Read ↗

Chronic mast cell leukaemia with exon 9 KIT mutation A502_Y503dup: a rare imatinib responsive variant.Semantic proximity Read ↗

A case of de novo aleukemic mast cell leukemia without c-KIT mutations in exons 8 and 17.Semantic proximity Read ↗

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.Semantic proximity Read ↗

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.Semantic proximity Read ↗

Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin.Semantic proximity Read ↗

Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic cloneSemantic proximity Read ↗

A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML.Semantic proximity Read ↗

Myeloid neoplasms with mutated KIT: comparative clinicopathologic analysis of D816 vs. non-D816 variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.